Some might argue ‘moral enhancement’ medicine already exists — such as when we take medicine that alters our brain chemistry. Where do we draw a line?
Nigeria can save money spent importing citric acid by producing it from cashew waste.
Record-breaking technology can sequence an entire human genome in a matter of hours. The work could be a lifeline for people suffering from the more than 5,000 known rare genetic diseases.
Scientists are looking for safe new ways to prevent ice from damaging food in frozen storage, which costs consumers billions of dollars a year in wasted food.
The FDA approved Alzheimer’s disease drug aducanumab despite minimal evidence of its efficacy. Whether this decision ultimately hurts or helps patients depends on data researchers don’t yet have.
We may never know whether the pandemic began with a leak at the Wuhan lab. But even the possibility shows we need a universal biosafety code to prevent something similar happening in future.
Skyrocketing demand coupled with shortages of vital components is leading to bottlenecks in the supply chain of Pfizer’s and other mRNA vaccines.
We have two mRNA COVID-19 vaccines so far. But what else can this technology do?
Plant scientists hope to avoid a repeat of the GM foods debate from two decades ago.
Medical innovation is often accelerated in a time of crisis.
Global long-term data simply doesn’t exist for jellyfish, so scientists struggle to predict, track and mitigate their potential effects.
COVID-19 tests rely on a process developed at a biotech company co-founded by a Canadian. Canada’s current testing expertise needs to be channelled to prepare for the next wave, and the next pandemic.
The results from the phase 1 trial are a promising first step in showing that the mRNA vaccine is a viable candidate, but there are unanswered questions and it is still early in the process.
A new biotech regulation allows companies to self-police and decide which crops should be regulated. The new rule is likely to amplify greater distrust of GM crops.
Biohackers and other ‘connoisseurs of science’ have important social and scientific contributions to make.
Golden Rice – a controversial genetically modified product designed to combat malnutrition – has been approved as safe in the Philippines. But key questions remain unanswered.
Xenobots have been called the world’s first “living robots”. They are made entirely of living tissue, and can be programmed to move towards a certain object.
Bigger penalties for pirating plants could help encourage growers to develop new varieties.
Synthetic biology lets us explore places where evolution has never gone, to help meet humanity’s food needs in a future shaped by climate change.
Governments fail to imagine how worst-case scenarios can come about – much less plan for them. But there are things we can do.